PS Pharma Service

What PS Pharma Service does

PS Pharma Service GmbH is a German specialty pharmaceutical service provider founded in 1994 and headquartered in Meerbusch, operating as a subsidiary of the Semdor Pharma Group since the 2021 merger of the PS Group and Cannamedical Pharma. The company provides full-service handling of narcotics (Betäubungsmittel, BtM) and medical cannabis, including GMP-certified contract manufacturing (§ 13 AMG), primary and secondary packaging, GMP/GDP-certified storage in high-security vaults, import/export with BfArM permit handling, stability testing under ICH conditions, and a white-label EU-GMP cannabis offering. Its core technical infrastructure comprises certified BtM vaults (resistance grade III or higher), modern climatic chambers for stability studies, validated GMP packaging processes, serialization for FMD compliance, and an in-house GDP-certified temperature-controlled fleet.

The business serves three primary customer segments: established pharmaceutical companies requiring BtM manufacturing and packaging, German wholesalers and licensed dealers using the firm for distribution and white-label sourcing, and German pharmacies as downstream recipients of narcotics and cannabis products. Revenue mechanics are quote-based, contract-driven B2B professional services priced per batch, lane, or project on multi-year arrangements; no public pricing exists and revenue is not disclosed. The go-to-market is sales-led with phone and email consultation, industry trade-show presence, a newsletter ("Cannalivery"), and a registered wholesale portal that requires BTM license documentation.

Operationally, the company has executed a multi-year capacity expansion culminating in a 2023 €8 million capex program adding roughly 5,000 new pallet spaces, alongside the planned launch of a white-label BtM shop system. The firm holds GMP, GDP, and EU-GMP certifications and the full set of German narcotics-related authorizations, positioning it as a regulatory bottleneck for cannabis and BtM supply chains into the German pharmaceutical market.

Name

PS Pharma Service

Legal name

PS Pharma Service GmbH

Website

https://pspharmaservice.de

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

51–100 employees

Short description

PS Pharma Service GmbH is a German GMP/GDP-certified specialty pharma services provider offering narcotics storage, contract manufacturing, primary packaging, import/export, and white-label medical cannabis solutions to pharmaceutical companies, wholesalers, and pharmacies.

Ownership category

akta.pro rank

Product category

Pharmaceutical Logistics Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Pharmaceutical Preparation Manufacturing (325412), Refrigerated Warehousing and Storage (493120)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI)

akta.pro secondary industries

Third-Party White-Label Ordering & Delivery Platforms (SaaS + Logistics) (CRANAGAF), Cannabis Wholesale Distribution (Flower, Extracts, Edibles) (CRAOAIAF), Pharma & Life Sciences Cold Chain Forwarding (GDP-Compliant) (TLACAMAD)

Keywords

• Pharmaceutical logistics services
• Narcotics handling
• Medical cannabis packaging
• Contract pharmaceutical manufacturing
• GMP certified distribution

Headquarters

HQ city

Meerbusch

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Supply Chain, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Contract Manufacturing Services: Lohnherstellung (contract manufacturing) with manufacturing authorization under § 13 AMG. Customers outsource production to reduce personnel and machine costs.
2. Storage and Distribution: GDP-certified storage and distribution of narcotics and medical cannabis products. Includes own fleet of temperature-controlled vehicles.
3. Packaging and Repackaging: GMP-certified packaging of narcotics ranging from small batches to entire bulk batches. Also includes primary packaging of cannabis flowers and extracts.
4. Import and Export Services: Complete handling of narcotics import/export with full responsibility. Handles applications and documentation for BfArM permits.
5. White-Label Cannabis Products: Sourcing and distribution of EU-GMP certified white label cannabis products for licensed distributors to establish their own cannabis brands.
6. Regulatory Affairs Services: Support for drug registration, approval processes, and regulatory compliance for parallel imports and generics.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

PS Pharma Service GmbH provides B2B full-service pharmaceutical logistics and contract manufacturing for narcotics (BtM) and medical cannabis. Services span the complete value chain including GMP-certified contract manufacturing, primary packaging of cannabis flowers, secure BtM vault storage, GDP-certified distribution with own temperature-controlled fleet, import/export handling with BfArM permit processing, white-label cannabis products, stability testing, and regulatory affairs support. All services are delivered from a GMP/GDP-certified facility in Meerbusch, Germany.

Product overview

PS Pharma Service GmbH is a full-service pharmaceutical logistics provider specializing in narcotics (BtM) and medical cannabis handling. The company operates a platform-based service model offering integrated cannabis services (primary packaging, labeling, relabeling, white-label products, storage, stability testing, and distribution) alongside general narcotics services (contract manufacturing, storage, packaging, import/export, and regulatory affairs). Services are provided from a GMP/GDP-certified facility in Meerbusch, Germany, with complete value chain coverage from import through manufacturing, packaging, storage, and distribution.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Storage capacity expanded by ~5,000 new pallet spaces through recent €8 million investment

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Semdor Pharma GroupcoreStrategic or Co-development Partner · 1 January 2021PS Pharma Service GmbH is a subsidiary of Semdor Pharma Group, one of Europe's leading specialty pharmaceutical companies focused on narcotics and medical cannabis. Semdor Pharma Group was formed in 2021 through the merger of the PS Group (including PS Pharma Services, PB Pharma, and PS Marketing & Outsourcing) with Cannamedical Pharma. The group offers the broadest portfolio of narcotics (both synthetic and natural) and provides market-leading services in import, handling, packaging, and formulation.
• PB Pharma GmbHcoreStrategic or Co-development Partner · 1 January 2021PB Pharma GmbH offers a nearly complete range of BtM products as reimport and parallelimport medicines, belonging to the leading providers in this sensitive area. Part of the PS Pharma and PB Pharma strong team partnership within the Semdor Group.
• German Pharmacies and WholesalerscoreChannel Partner/ Reseller/ DistributorA large proportion of German pharmacies and wholesalers are already qualified partners of PS Pharma Service GmbH, providing distribution reach for customers' products.

Scale indicators6 records

Recent moves11 records

Expansion highlights5 records

Broad incumbents

• PCI Pharma Services: Global pharma services provider focused on contract manufacturing, clinical trial supply and commercial packaging. Comparable in providing integrated CDMO and packaging services to pharmaceutical sponsors with regulatory and quality infrastructure.
• Siegfried Holding AG: Swiss-listed pharmaceutical CDMO providing API and finished drug product manufacturing including packaging. Comparable as a European CDMO serving global pharma with integrated manufacturing, packaging and regulatory services.
• Eurofins CDMO (Eurofins PHA Discovery / Eurofins spin-offs): Eurofins operates pharmaceutical services and CDMO activities in Europe including stability, packaging and regulatory services. Comparable as a large European provider of GMP/GDP-aligned pharmaceutical testing, storage and packaging services.
• B. Braun Medical SA / B. Braun Pharma Services: German-headquartered medical technology and pharmaceutical services group with contract manufacturing, sterilization and packaging for pharma customers. Comparable as a large German-rooted pharma manufacturer with GMP-certified packaging and contract services infrastructure.
• Catalent, Inc. Global pharmaceutical CDMO with a large softgel and sterile injectable business plus oral solid and biologics capabilities. Overlapping business model as a CDMO serving pharma customers with GMP-certified packaging and manufacturing services.
• Vetter Pharma-Fertigung GmbH & Co. KG: A leading German contract development and manufacturing organization (CDMO) for sterile injectables and complex pharmaceutical products. Highly comparable as a German-headquartered pharmaceutical CDMO serving global pharma with GMP-certified manufacturing, packaging and quality services.

Direct peers

• Demecan GmbH: German medical cannabis producer and distributor with vertically integrated cultivation, processing and distribution. Comparable as a German-headquartered company serving the medical cannabis market; represents both a partnership and competitive dynamic for PS Pharma's white-label offerings.
• Aenova Holding GmbH: German-headquartered CDMO offering contract manufacturing and packaging for solid, semi-solid and liquid dosage forms. Closely comparable contract-manufacturing and packaging model targeting pharmaceutical companies under GMP standards.
• Cansativa GmbH: German medical cannabis wholesaler and platform serving pharmacies and patients. Comparable as a German-headquartered medical cannabis intermediary that overlaps with PS Pharma's wholesale distribution and pharmacy delivery services.

Emerging players

• Bedrocan International B.V. Dutch producer of pharmaceutical-grade medicinal cannabis flowers under contract with the Dutch Ministry of Health. Overlapping category in medical cannabis; although PS Pharma is a service provider and Bedrocan a cultivator, the two intersect at the German packaging/relabeling step.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/ps-pharma-service

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PS Pharma Service